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Campylobacter jejuni is the main causative agent of food-borne diarroheal illness in the UK and most of the 
developed world. In addition, it is a significant cause of morbidity and mortality in infants in the developing world. It 
causes symptoms that range from mild, self-limiting disease to more severe haemorrhagic diarrhoeal disease that can 
last up to two weeks and in some cases even relapse1. In addition, C. jejuni can also cause long-lasting sequelae, which 
include Guillane-Barré syndrome and reactive arthritis2. In the UK alone, the total burden of campylobacteriosis is 
estimated to reach over 700,000 cases per year3, at an estimated cost to the economy of £500 million4. The main 
source of campylobacteriosis is the consumption of contaminated poultry which has been attributed to up to 80% of 
human infections5. In the UK, a recent year-long survey estimated that, in 2014, an average of 70% of poultry carcases 
on retail were contaminated with Campylobacter6. Even though it is the main zoonotic food-borne pathogen, the 
biology of C. jejuni and its interactions with the chicken’s immune system is not as well understood as other 
pathogens, such as E. coli and Salmonella. in chickens, Campylobacter resides in the intestinal mucus and invasion 
levels are low1. Historically, C. jejuni was described as a commensal organism in chickens, as it does not cause overt 
clinical signs. However, C. jejuni can be isolated from the liver of infected chickens, which is the main cause of 
campylobacteriosis outbreaks in the UK3; this internal organ infiltration is not typically considered commensal 
behaviour. The reasons behind C. jejuni’s biology of infection in chickens are still not well understood and the relative 
contributions of the chicken’s immune response to infection vs. the ability of Campylobacter to invade and to evade 
or subvert the immune response are still not well characterised. 
In this issue of Virulence, Vaezirad et al7 describe how treatment of chickens with glucocorticoids (GC), which 
induce generalised immunosuppression, influences the invasive behaviour of C. jejuni. The data suggest that C. jejuni 
has the intrinsic ability to translocate the intestinal barrier and disseminate to the liver. However, the chicken is able 
to mount an effective early innate immune response which appears to be partially responsible for limiting the amount 
of tissue and organ infiltration in chickens. This study demonstrated that, following GC treatment, both caecal 
colonisation levels and the invasion of C. jejuni into the liver were significantly increased when monitored daily during 
the first four days after infection. To my knowledge, this is the first publication to demonstrate an increased 
colonisation and invasion of C. jejuni within the liver following experimental immunosuppression in chickens. 
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To demonstrate the induction of an innate immune response following C. jejuni infection, Vaezirad and co-
workers7 measured the induction of pro-inflammatory gene expression after infection. Following C. jejuni infection of 
non-GC treated chickens, statistically significant increases of various magnitude in the pro-inflammatory cytokines IL-
8, IL-6, IL-1β and iNOS were observed in both the spleen and the liver at days 1 and 4 after infection. No increase in 
IFNβ was observed in these birds. GC treatment without C. jejuni infection was shown to induce significant decreases 
in the expression of these genes at various time-points in the caecum but no changes in expression of these genes 
were observed in the spleen. When the expression level of these genes was compared in GC-treated and non-treated 
chickens, both C. jejuni challenged, reductions in the expression of most of these gene were observed at both time-
points and in both organs, suggesting effective suppression of the innate immune response mounted against C. jejuni 
infection. These results demonstrate that chickens are able to mount an effective early innate immune response 
against C. jejuni infection and that this response is ablated following immunosuppression with GC treatment. They 
also confirm that gene expression for the IL-8, IL-6 and IL-1β cytokines, which were observed to be significantly 
induced in chicken cell lines in vitro8, is also induced in vivo. Gene expression during Campylobacter infection was 
compared to that induced by Salmonella Enteritidis and pathogen specific differences were observed. 
The present study by Vaezirad et al7 provides another experimental confirmation that C. jejuni is not merely a 
commensal organism in chickens. Previously, Bull et al9 reported an association between C. jejuni positivity and an 
increase in the incidence of pododermatitis in commercial flocks. The causative link between C. jejuni infection and 
pododermatitis was later and for the first time proven experimentally by Humphrey et al10, who also revealed 
differences in the immune response to Campylobacter infection in different breeds of chickens. Humphrey et al10 
highlighted that increased IL-10 gene expression at 12 days post infection (dpi) resulted in reduced intestinal 
pathology and lower incidence of pododermatitis. Further, it has been shown that chickens can produce high levels of 
IL-10 early in infection with other pathogens. For example, Setta et al11 described a significant induction of IL-10 at 4 
dpi with S. Enteritidis (which colonises the intestines but does not invade significantly or cause clinical signs) but not 
after infection with S. Gallinarum or S. Pullorum (which cause typhoidal-like disease but do not colonise the 
intestines). In contrast, Shaughnessy et al12 showed that, even though both activate TLR-4 to similar levels, S. 
Typhimurium (which, like S. Enteritidis, colonises the intestines but does not cause clinical signs) but not C. jejuni 
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infection induces a significant increase in the expression of IFNγ. Increased IFNγ gene expression has been correlated 
with a decrease in severity of clinical signs due to campylobacteriosis in humans, supporting the hypothesis that a 
Th1-polarised immune response has the primary role in acquired immunity to C. jejuni13. Taken together, these 
observations suggest that a finely balance induction of both IL-10 and IFNγ may be required for the clearance of 
bacterial intestinal pathogens in chickens. Given this, an insight into the expression of this cytokine early in infection 
with C. jejuni would be valuable information, a cytokine that the authors unfortunately did not look at in the present 
study. As a result, further work investigating the expression of both IL-10 and IFNγ along the course of C. jejuni 
infection is required to assess the role of these cytokines in this infection. 
While this study adds a valuable insight into the biology of C. jejuni infection in chickens, the fine mechanistic 
details of the interaction of C. jejuni with the chicken immune response remain to be elucidated. To gain some insight 
into the mechanisms behind their observation, Vaezirad et al7 investigated the induction of iNOS in two macrophage 
cells lines in vivo following GC-treatment and C. jejuni stimulation. They demonstrated that iNOS gene expression was 
abolished in GC pre-treated cells compared to non-treated control cells. This observation suggests a role for 
macrophages in the defence against C. jejuni invasion in chickens. However, C. jejuni survival ability within these GC-
treated macrophage cell lines was not assessed. Furthermore, these observations were not validated in vivo, possibly 
due to the lack of widely available tools. The use of recently developed tools such transgenic chickens that express 
fluorophores on the cells of the macrophage lineage14 and a C. jejuni 11169H strain that expresses GFP stably and to 
high levels from a chromosomal integration15 could facilitate a more precise study of interactions between C. jejuni 
and macrophages and other cells of the immune system in vivo. 
Overall, the nature of the protective immune response required to avoid C. jejuni colonisation remains to be 
fully elucidated. Previous studies looked at a limited number of genes over a limited time-course using different 
breeds of chickens. As such, further studies investigating the expression of an increased number of immune genes, 
both early and late in the course of the same infection, in a single breed of chickens, are required to characterise host-
pathogen interactions in more detail. These should be complemented by in vivo studies of changes in populations of 
immune cells during C. jejuni infection in order to determine whether changes that may be observed at the level of 
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gene expression are due to true changes in gene expression or local changes in cell populations. Such information 
could aid the rational development of control strategies such as vaccination. Vaccines have been proven to be 
protective by independent research groups 16,17,18, however, the nature of the protective immune response remains to 
be elucidated. Recently developed transgenic chickens that lack functional antibodies19, would provide a valuable 
insight into the nature of protective immune response following vaccination. 
In summary, while the data presented by Vaezirad et al7 represents a valuable addition to our understanding 
of the early host-pathogen interactions in Campylobacter infection in chickens, there are still major gaps in our 
understanding of the interaction of C. jejuni with the immune system of the chicken. Only with a more detailed study 
of these basic aspects we hope to rationally develop control strategies and even make effective vaccination feasible. 
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